Emerging Carotid Artery Stenting and Embolic Protection Devices Leading the U.S. Stroke Management Market to $6 Billion in Sales in 2008, According to a New Analysis from Medtech Insight.

NEWPORT BEACH, Calif. -- Stroke -- a sudden and often catastrophic disruption in the delivery of oxygen and nutrients to the tissues of the brain -- is the third-leading cause of death in the United States. There will be approximately 282,000 fatalities from stroke this year, half of which will occur outside a hospital. Products used to manage stroke patients include diagnostic imaging systems, pharmaceuticals, and surgical and interventional systems to help prevent, quickly limit neurological damage after acute stroke, and minimize the probability of recurrent cerebral accidents in stroke survivors. The U.S. market for these products, valued at approximately $3.6 billion in 2003, is expected to reach nearly $6 billion by 2008.

Medtech Insight announces the publication of a new Market & Technology Report that provides a thorough analysis of the market for products used in the diagnosis and therapy of stroke, and the companies responsible for their development, titled "U.S. Markets for Stroke Management Products." It examines the following markets, from 2003 forecast to 2008: stroke diagnostic imaging systems including computed tomography, magnetic resonance imaging, diagnostic ultrasound, angiography, and nuclear imaging products; drug therapy products including nonsteroidal anti-inflammatory drugs, oral antiplatelet, anticoagulation, antihypertensive and anticonvulsive agents, and intravenous thrombolytic agents; and neurovascular surgical and interventional products including aneurysm/arteriovenous malformation surgical clips, endovascular embolization systems, and emerging products such as embolic protection systems, carotid artery stenting systems, microcatheter-based cerebral thrombectomy systems, and cooling technologies. It is these emerging devices that will be the primary drivers of market growth over the next few years, as they gain wider use.

Fourteen detailed company profiles are also included in this analysis, in addition to 65 exhibits, a clinical and statistical overview of stroke, and information on stroke management resources and initiatives.

Companies whose products and strategies are covered in the report include: Abbott Laboratories, Aesculap/B. Braun, Boston Scientific, Concentric Medical, Cook, GE Healthcare, Genentech, Guidant, Johnson & Johnson, Medtronic, Mizuho America, Pfizer, Philips Medical Systems, and Siemens, among many others. A full table of contents for this report and ordering information can be viewed at http://www.medtechinsight.com/ReportA225.html.

Now a division of Windhover Information Inc. (www.windhover.com), publisher of IN VIVO: The Business & Medicine Report and Start-UP: Windhover's Review of Emerging Technologies, Medtech Insight is a leading provider of business information for the medical technology marketplace. The company publishes the monthly "medtech insight" newsletter and a wide selection of comprehensive Market & Technology Reports, holds several medtech investment and partnering conferences annually, and provides custom consulting services. The company has just introduced the availability of their "EU I.Q." European Surgical Procedures Database, the most comprehensive and up-to-date source for European healthcare market statistics available.